Pieter R. Cullis

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Biochemistry, Molecular Biology
Google:
"Pieter Cullis"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fenske DB, Chonn A, Cullis PR. (2008) Liposomal nanomedicines: an emerging field. Toxicologic Pathology. 36: 21-9
Fenske DB, Cullis PR. (2008) Liposomal nanomedicines. Expert Opinion On Drug Delivery. 5: 25-44
Finn JD, Wong T, Cullis PR. (2005) Investigation of factors responsible for cell line cytoplasmic expression differences. Bmc Molecular Biology. 6: 11
Sandhu AP, Lam AM, Fenske DB, et al. (2005) Calcium enhances the transfection potency of stabilized plasmid-lipid particles. Analytical Biochemistry. 341: 156-64
Abraham SA, Waterhouse DN, Mayer LD, et al. (2005) The liposomal formulation of doxorubicin. Methods in Enzymology. 391: 71-97
Waterhouse DN, Madden TD, Cullis PR, et al. (2005) Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Methods in Enzymology. 391: 40-57
Fenske DB, Cullis PR. (2005) Entrapment of small molecules and nucleic acid-based drugs in liposomes. Methods in Enzymology. 391: 7-40
Chen T, Palmer LR, Fenske DB, et al. (2004) Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. Journal of Liposome Research. 14: 155-73
Palmer LR, Chen T, Lam AM, et al. (2003) Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochimica Et Biophysica Acta. 1611: 204-16
Fenske DB, MacLachlan I, Cullis PR. (2002) Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods in Enzymology. 346: 36-71
See more...